Year All20242023202220212020201920182017201620152014 Oct 23, 2019 Soleno Therapeutics Announces Pricing of $13.4 Million Public Offering of Common Stock Oct 22, 2019 Soleno Therapeutics Announces Proposed Public Offering of Common Stock Oct 02, 2019 Soleno Therapeutics Announces Positive Outcome from Second Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome Sep 24, 2019 Soleno Therapeutics Announces Publication of Results from Previously Completed Phase II Trial of DCCR for Treatment of Prader-Willi Syndrome Sep 19, 2019 Soleno Therapeutics to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies Aug 07, 2019 Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2019 Financial Results Jul 25, 2019 Soleno Therapeutics Provides Update on Ongoing DESTINY PWS Phase III Trial of DCCR in Prader-Willi Syndrome Jun 12, 2019 Soleno Therapeutics Announces Appointment of Veteran Industry Executive Birgitte Volck, M.D., Ph.D., to Board of Directors May 13, 2019 Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2019 Financial Results Apr 29, 2019 Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors
Oct 02, 2019 Soleno Therapeutics Announces Positive Outcome from Second Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome
Sep 24, 2019 Soleno Therapeutics Announces Publication of Results from Previously Completed Phase II Trial of DCCR for Treatment of Prader-Willi Syndrome
Sep 19, 2019 Soleno Therapeutics to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies
Aug 07, 2019 Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2019 Financial Results
Jul 25, 2019 Soleno Therapeutics Provides Update on Ongoing DESTINY PWS Phase III Trial of DCCR in Prader-Willi Syndrome
Jun 12, 2019 Soleno Therapeutics Announces Appointment of Veteran Industry Executive Birgitte Volck, M.D., Ph.D., to Board of Directors
May 13, 2019 Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2019 Financial Results
Apr 29, 2019 Soleno Therapeutics Announces Appointment of Industry Veteran Gwen A. Melincoff to Board of Directors